Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Express Scripts
Queensland Health
Fuji
Citi
Covington
Accenture
Federal Trade Commission

Generated: July 18, 2018

DrugPatentWatch Database Preview

Chartwell Molecules Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty approved drugs.



Summary for Chartwell Molecules
US Patents:0
Tradenames:15
Ingredients:15
NDAs:20

Drugs and US Patents for Chartwell Molecules

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET;ORAL 074093-003 Nov 5, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Molecules NABUMETONE nabumetone TABLET;ORAL 076009-002 Jan 24, 2003 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Molecules ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077303-002 Jun 25, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Molecules ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077303-001 Jun 25, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Citi
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
McKinsey
Deloitte
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.